Status:
UNKNOWN
Immune Repertoire of Ovarian HGSC
Lead Sponsor:
Lei Li
Conditions:
Ovarian High Grade Serous Carcinoma
Immune Repertoire
Eligibility:
FEMALE
18+ years
Brief Summary
In this preliminary study, peripheral blood and carcinoma tissue with pericarcinomatous tissue are taken from the patients with ovarian high grade serous carcinoma at several points: before any treatm...
Eligibility Criteria
Inclusion
- Confirmed of primary ovarian high grade serous carcinoma
- Aged 18 years or older
- No immunosuppressive disease
- Signed an approved informed consents
Exclusion
- Not meeting all of the inclusion criteria
Key Trial Info
Start Date :
January 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03794115
Start Date
January 3 2019
End Date
January 1 2022
Last Update
January 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Li
Beijing, Beijing Municipality, China, 100730